22057 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Kris
    Kris
  5. Saltz
    Saltz
  6. Offit
    Offit
  7. O'Reilly
    O'Reilly
  8. Solit
    Solit
  9. Robson
    Robson
  10. Drilon
    Drilon

Groups

  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)
  7. Breast Medicine Service (4103)
  8. Surgery (4019)
  9. Department of Pathology and Laboratory Medicine (3422)
  10. Thoracic Oncology (3351)
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma
    Journal Article

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Baxi, S.; Katabi, N.; Antonescu, C. R.; Ostrovnaya, I.; Haque, S. S.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
    Journal Article

    Schlappe, B. A.; Zhou, Q. C.; O'Cearbhaill, R.; Iasonos, A.; Soslow, R. A.; Abu-Rustum, N. R.; Mueller, J. J.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Geriatric assessment, not ASA physical status, is associated with 6-month postoperative survival in patients with cancer aged ≥75 years
    Journal Article

    Shahrokni, A.; Vishnevsky, B. M.; Jang, B.; Sarraf, S.; Alexander, K.; Kim, S. J.; Downey, R.; Afonso, A.; Korc-Grodzicki, B.
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma
    Journal Article

    Wang, T.; Drill, E.; Vakiani, E.; Pak, L. M.; Boerner, T.; Askan, G.; Schvartzman, J. M.; Simpson, A. L.; Jarnagin, W. R.; Sigel, C. S.
    Human Pathology (2019)

    Fulltext@MSK | Save
  • Duration of adjuvant chemotherapy in colon cancer: Current standards and new updates
    Review

    Greally, M.; Ilson, D. H.
    Current Colorectal Cancer Reports (2019)

    Fulltext@MSK | Save
  • Modifiable host factors in melanoma: Emerging evidence for obesity, diet, exercise, and the microbiome
    Review

    Warner, A. B.; McQuade, J. L.
    Current Oncology Reports (2019)

    Fulltext@MSK | Save
  • Novel RB1-loss transcriptomic signature is associated with poor clinical outcomes across cancer types
    Journal Article

    Chen, W. S.; Alshalalfa, M.; Zhao, S. G.; Liu, Y.; Mahal, B. A.; Quigley, D. A.; Wei, T.; Davicioni, E.; Rebbeck, T. R.; Kantoff, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical and genome-wide analysis of cisplatininduced tinnitus implicates novel ototoxic mechanisms
    Journal Article

    El Charif, O.; Mapes, B.; Trendowski, M. R.; Wheeler, H. E.; Wing, C.; Dinh, P. C. Jr; Frisina, R. D.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Toxicities of checkpoint inhibitors: Causes and management [interview]
    Journal Article

    Postow, M. A.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save